|1.||Anisimov, Vladimir N: 6 articles (11/2015 - 01/2003)|
|2.||Pollak, Michael: 5 articles (12/2014 - 09/2010)|
|3.||Menendez, Javier A: 3 articles (05/2015 - 03/2010)|
|4.||Martin-Castillo, Begoña: 3 articles (05/2015 - 03/2010)|
|5.||Topisirovic, Ivan: 3 articles (12/2014 - 06/2012)|
|6.||Pollak, Michael N: 3 articles (09/2014 - 09/2012)|
|7.||Tenenbaum, Alexander: 3 articles (01/2009 - 05/2004)|
|8.||Fisman, Enrique Z: 3 articles (01/2009 - 05/2004)|
|9.||Thompson, Matthew D: 2 articles (06/2015 - 12/2012)|
|10.||Thompson, Henry J: 2 articles (06/2015 - 12/2012)|
02/11/2013 - "In this issue of Cancer Cell, Shackelford and colleagues show, paradoxically, that biguanides are more effective in the treatment of mouse tumors that lack a functional LKB1-AMPK pathway."
06/01/2014 - "The present review focused on some details of experiments such as design of studies, dose and route of administration of biguanide, and age of animals at start of treatment etc. Conclusion may be done that there are rather sufficient evidence of cancer-preventive activity of antidiabetic biguanides in experimental animals. "
09/01/2010 - "Such trials may define important new indications for biguanides in the prevention and/or treatment of many common cancers."
03/01/2015 - "Biguanides, used for anti-diabetic drugs, bring more attention in cancer research for their beneficial effects. "
03/01/2015 - "Biguanides and targeted anti-cancer treatments."
05/01/1976 - "Biguanides of prolonged action were highly effective in obese patients with diabetes mellitus of moderate severity. "
01/01/1978 - "[Ergospirometric studies on patients with diabetes mellitus and the effect of biguanides on physical performance]."
06/01/2011 - "The use of biguanides, sulphonylurea and other drugs are valuable in the treatment of diabetes mellitus; their use, however, is restricted by their limited action, pharmacokinetic properties, secondary failure rates and side effects. "
08/15/1997 - "Biguanides have been used in treatment of diabetes mellitus for over 30 years now. "
09/01/1996 - "[The pharmacological blockade of protein glycosylation in diabetes mellitus using sulfonylurea derivatives and biguanides]."
01/01/1992 - "In 1992, among these compounds, specific of insulin resistance, biguanides are mostly used. "
12/01/2011 - "Two drug groups today target insulin resistance; biguanides and thiazolidinediones. "
01/01/2007 - "Biguanides and thiazolidinediones (TZDs) are two classes of oral agents for the management of DM2 that improve insulin resistance, and thus have potential cardiovascular benefits beyond glycemic control alone. "
02/12/2000 - "Rapid-release analogs and alpha-glucosidase inhibitors appear to be promising; biguanides affect insulin resistance."
09/01/1993 - "Biguanides like metformin have also been found to reduce insulin resistance."
08/01/1971 - "[Antidiabetic biguanides in the prevention of fatty liver induced by high-fat diet in rabbits. "
01/01/2014 - "Obesity was an aggravating factor for fatty liver disease, and biguanides were useful as counteractants. "
04/01/2005 - "The improvement in liver function parameters known to be associated with fatty liver in the present study, together with an improvement in fatty liver reported for another class of insulin sensitizers, biguanides, suggests that thiazolidinediones may have a beneficial effect on fatty liver."
01/01/2011 - "Biguanides have been developed for the treatment of hyperglycemia and type 2 diabetes. "
01/01/2004 - "There is evidence to indicate that controlling hyperglycemia by antidiabetic biguanides prolongs life span in experimental animals. "
01/01/2013 - "Several drugs such as sulfonylureas and biguanides are presently available to reduce hyperglycemia in diabetes mellitus. "
01/01/1984 - "It is proposed that contraindications to the use of biguanides in diabetes mellitus patients should also include hyperglycemia. "
01/01/1990 - "Since biguanides are known to induce lactate acidosis, blood serum lactic acid levels were measured when the patients were hospitalized, in the presence of hyperglycemia, and then after a standard exercise test (to detect latent acidosis). "
|9.||Glucagon-Like Peptide 1 (GLP 1)
|3.||Drug Therapy (Chemotherapy)